Omnitrope 5 mg

Omnitrope 5 mg is a medicine authorised by Swissmedic under authorisation number 61306. The authorisation holder is Sandoz Pharmaceuticals AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 27 July 2010 and the authorisation is valid without a time limit. ATC code H01AC01 places the medicine in the group Pituitary and hypothalamic hormones and analogues.

  • Dispensing category A
  • Authorisation number 61306
  • ATC H01AC01
  • Biotechnological medicines
Authorisation data
Authorisation number61306
NameOmnitrope 5 mg
Full nameOmnitrope 5 mg, Injektionslösung
Authorisation holderSandoz Pharmaceuticals AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeH01AC01
First authorisation27 July 2010
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Omnitrope 5 mg, InjektionslösungA27 July 2010
2Omnitrope 10 mg, InjektionslösungA27 July 2010
3Omnitrope 15 mg, InjektionslösungA01 September 2014

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
75StückH01AC0107.03.1.A
810StückH01AC0107.03.1.A
111StückH01AC0107.03.1.A
95StückH01AC0107.03.1.A
1010StückH01AC0107.03.1.A
121StückH01AC0107.03.1.A
51StückH01AC0107.03.1.A
65StückH01AC0107.03.1.A

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Omnitrope 5 mg authorised in Switzerland?

Yes. Omnitrope 5 mg is authorised by Swissmedic under authorisation number 61306, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Omnitrope 5 mg have?

Omnitrope 5 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Omnitrope 5 mg?

The authorisation holder is Sandoz Pharmaceuticals AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com